DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 214 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,208 | +30.6% | 81,806 | +14.3% | 0.01% | +50.0% |
| Q2 2023 | $925 | -8.9% | 71,574 | -30.8% | 0.01% | 0.0% |
| Q1 2023 | $1,015 | +686.8% | 103,443 | +754.9% | 0.01% | +300.0% |
| Q4 2022 | $129 | -100.0% | 12,100 | -92.1% | 0.00% | -90.5% |
| Q1 2022 | $1,667,000 | +526.7% | 153,758 | +468.5% | 0.02% | +600.0% |
| Q2 2021 | $266,000 | -64.3% | 27,045 | -64.3% | 0.00% | -72.7% |
| Q1 2021 | $745,000 | +244.9% | 75,739 | +51.3% | 0.01% | +175.0% |
| Q3 2020 | $216,000 | +28.6% | 50,048 | +70.5% | 0.00% | +33.3% |
| Q4 2019 | $168,000 | – | 29,346 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |